#express pharma magazine subscription

[magsubs]

Pharma Trends & Updates: Your Subscription to Success

Express Pharma Magazine, founded in 1994 as Express Pharma Pulse, has established itself as a premier fortnightly journal addressing the needs of the pharmaceutical business in Delhi, India. Over the years, we have won our readers' trust and support, cementing our position as the sector's leading business news magazine. Express Pharma Magazine takes pleasure in providing comprehensive and timely journalistic articles covering many aspects of the pharmaceutical sector.

Our magazine is divided into four unique segments, each of which provides valuable insights and perspectives: Market: Stay current on the latest market trends, business developments, and regulatory updates affecting the pharmaceutical industry. From mergers and acquisitions to market analysis and forecasts, our Market segment provides you with the information you need to make sound strategic decisions. Management: Discover effective management tactics, leadership techniques, and best practices tailored to the pharmaceutical industry. Our Management category helps industry experts handle problems, optimise operations, and promote organisational success.

Research: Explore cutting-edge research, innovations, and breakthroughs in drug development. The Research segment serves as a platform for scientists, researchers, and experts to share expertise, explore emerging therapies, and stay updated on advancements in the field.

Pharma Life: Addressing HR challenges specific to the pharmaceutical industry, our Pharma Life segment covers topics such as talent acquisition, workforce management, training, and employee engagement. Stay informed about HR trends and strategies shaping the industry workforce.

In addition to our regular content, Express Pharma Magazine publishes quarterly special editions including Pharma Technology Review, Packaging Special, and LABNEXT, focusing on technological advancements, packaging innovations, and laboratory practices.

To take advantage of our abundance of information and perspectives, we welcome you to subscribe to Express Pharma Magazine. Subscribers receive exclusive content, expert interviews, incisive analysis, and current news updates. Express Pharmaceutical Magazine Subscriptions in India are intended to provide the greatest service experience. Choose the subscription option that best suits your needs—digital, print, or hybrid. Join a community of industry professionals who use our publication to stay informed, make strategic decisions, and contribute to the success of the pharmaceutical business. For subscription inquiries, please visit our website or contact our customer service department. Express Pharma Magazine Subscription to help you understand the pharmaceutical sector's potential and stay ahead of industry changes.

[magazinesubscriptions11]

Latest Pharmaceutical Magazine Subscription 2024

These magazines have significance for keeping people in the pharmaceutical industry Get up with the latest news, and trends, and come out on top. We'll talk about the content, topics of interest, and why each of these journals is important to those in the sector. 

BioSpectrum India is a term that shows advanced biopharmaceutical concepts. For anyone wanting a full knowledge of the pharmaceutical industry in 2024, a BioSpectrum magazine subscription is a definite requirement.

BioSpectrum India magazine is A reputed journal that supports India's growing bioscience and healthcare industries., BioSpectrum magazine is the leading website for experts in the industry. For people looking for a full explanation of Biospectrum India 2024. If you're interested in biospectrum magazine subscription, The most recent industry trends, or biospectrum journal It is your full guide.

Chronicle Pharmabiz Magazine

Chronicle Pharmabiz magazine separates itself among the best pharma magazines in India, serving an expanding pharmaceutical sector. Under the scope of Indian pharma magazines, It is noted for its outstanding customer care. Pharmabiz top news updates. The magazine serves as the main industry for noticed business experts.

If you want to learn everything about the pharmaceutical sector, a Chronicle Pharmabiz magazine subscription Is an intelligent wager. The Pharmabiz magazine subscription price is inexpensive and ensures getting hold of the latest Pharmabiz news and trends. It's not just a magazine; it's your key to following up with Pharmabiz Share Price Everything relating to the pharmaceutical sector in India at magazinesubscriptions.in.

Review Express Pharma's position in the industry and discuss the unique importance that separates it. Express Pharma Magazine is A popular journal in the pharmaceutical sector, Popular for its acute reporting. Get one of the best Express Pharma magazines It is an important asset for experts and fans.

For those who like to remain updated on the latest news and trends, an Express Pharma Magazine subscription is the best choice. The Express Pharma magazine subscription price is It provides access to high-quality information. It is more than just a magazine; it provides a single source for full details about the Indian pharmaceutical business, with the purpose of giving as many services as it can through its Express Pharma Magazine subscriptions in India.

Pharma Bio World magazine Is one of the best pharma magazines in India, Serving as an accurate guide for those in the industry. It stays out of Indian pharma magazines for its detailed examination of the evolving pharmaceutical sector. Its dedication to staying on the forefront of technology has enabled it to become famous as one of the top pharma magazines in India, Usually referred to as Pharma Times India.

Pharma Industrial India Magazine

Pharma Industrial India magazine is a major journal in the area of pharma manufacturing magazines And each of the best pharma magazines in India. It is popular for its pharmaceutical-related services and serves as an accurate resource for both specialists and kids. It is a useful instrument because it provides an in-depth review of the medicine—industry journal.

To stay informed about the most current developments and trends in the pharmaceutical sector, a Pharma Industrial India magazine subscription is the perfect option. It's not simply a pharmaceutical magazine; it's Your secret to gaining knowledge about industry advances and ideas. Keep informed about the pharmaceutical industry's Changes in this famous magazine.

____MAGAZINE SUBSCRIPTION IN INDIA_____    

Look no more than BioSpectrum India for the best pharmaceutical magazine. Pharmaceutical professionals rely on Biospectrum 2023 for guidance due to its reliance on delivering high-quality information. Subscribe to BioSpectrum India. at magazinesubscriptions.in Right now, to prevent missing out on the opportunity to expand your knowledge of the sector.

In the sections that follow, we will look at the remaining four magazines on our list, each of which provides essential data for pharmaceutical experts.

[jamieclawhorn]

One 6% and one 9% yielder I’d buy in 2018

There is no question in my mind that Stobart Group (LSE: STOB) has the capacity to keep doling out market-mashing dividends long into the future, thanks primarily to the massive earnings potential of its Aviation and Energy businesses.

In recent years the London-based business has been able to fund chunky payout hikes through the sale of non-core assets. And Stobart suggested that there is much more of that to come. The company said in December: “The group has non-operating asset resources available to support the dividend until 2022 and thereafter, dividends are expected to be funded out of operating profits.”

So despite expectations of a 74% earning slide in the year to February 2018, Stobart is still expected to keep dividends rising at an electrifying rate.

Last year’s 13.5p per share reward is anticipated to leap 28% in the current period, to 17.3p. And as a consequence the FTSE 250 business rocks up with a mammoth 6.2% yield. The good news does not stop here either, with City brokers predicting that the payout will rise an additional 6% in fiscal 2019 to 18.3p. This reading moves the yield to 6.5%.

At first glance, growth investors may be put off by the predicted earnings slump at Stobart this year. But this is expected to be a mere flash in the pan as the company is expected to hit back with a 276% bottom-line improvement next year.

Consequently Stobart’s toppy paper valuation, a forward P/E ratio of 134.8 times, falls to a much-improved 35.8 times for fiscal 2019. Sure, this reading also stands above the widely-accepted value watermark of 15 times or under. But a corresponding sub-1 PEG reading of 0.1 suggests Stobart is actually brilliantly valued relative to its growth prospects.

Another dividend star

Those seeking hot dividend stocks trading for next-to-nothing also need to pay Connect Group (LSE: CNCT) close attention.

Restructuring efforts are finally expected to push the newspaper and magazine distributor back into earnings growth after two successive annual reverses, and a 2% bottom line advance is predicted for the year to August 2018. And this results in a dirt cheap prospective P/E multiple of 7.2 times.

Thanks to its strong balance sheet, Connect has managed to overcome its recent profit woes and keep dividends chugging higher. And supported by this year’s expected earnings recovery and falling levels of debt, the business is anticipated to lift the payout again. The 9.8p per share reward forked out last year is expected to rise 2% in the current fiscal period to 10p.

And as a consequence Connect carries a quite astonishing 8.8% yield.

While the Swindon-headquartered business may have to do a hell of a lot of paddling to overcome tough trading conditions, it remains committed to further streamlining to create a formidable earnings generator in the coming years by concentrating on its core units.

Following on from the summer sale of its Education & Books division for a fee north of £50m, Connect hived off its Books division to Aurelius in December in a deal that could raise another £11.6m to bolster its financial firepower. And this gives me further confidence that the business can meet the Square Mile’s monster near-term dividend projections.

Get 2018 off to a bang with this dividend favourite

But Connect Group and Stobart Group are just a couple of the blue-chip beauties you can buy today and live off in the years to come.

Our analysts have been hard at work identifying a selection of the best FTSE 100 dividend stocks in the retail, pharma and utilities sectors, companies we are convinced should really kick-start your investment income. And they are revealed in The Motley Fool's 5 Shares To Retire On wealth report.

Click here to download the report. It's 100% free and comes with no further obligation, so why not take a look today?

More reading

This unloved 9% yielder could make you very rich

Royston Wild has no position in any of the shares mentioned.  The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.